BlackTreeCVE Intelligence
← Back to the CVE catalogue
Full vulnerability report · 2018
CVE-2018-10599High confidence

ICS-CERT IntelliVue Patient Monitors, Avalon Fetal/Maternal Monitors: Exposure of Sensitive Information to an Unauthorized Actor

ICS-CERT · IntelliVue Patient Monitors, Avalon Fetal/Maternal Monitors

5.3MediumCVSS 3.0
Recommended action
Scheduled

Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.

Fix not verified
R
Operational reassessment

Published severity in operational context

Open reassessment dashboard →
Published severityMediumOperational priority:Medium, unchanged from published severity.unchanged

Evidence used

  • No CISA KEV confirmation is currently recorded.
  • EPSS is 0.42% for the current model date.

Compensating controls

  • Restrict local access and enforce least privilege on affected hosts.
  • Monitor vendor guidance and exploitation sources for a material change.

Verification

  1. Confirm that the asset runs ICS-CERT IntelliVue Patient Monitors, Avalon Fetal/Maternal Monitors and falls inside the recorded affected range.
  2. Recheck the vendor advisory before scheduling a change because no verified fixed version is currently retained.
  3. Validate exposure, authentication requirements and compensating controls in the actual environment.
  4. Reopen this reassessment when CVSS, KEV, EPSS, exploit evidence or remediation changes.
Mitigation target: As exposure requiresRemediation target: Within 365 days

This automated reassessment organises public evidence. It does not know asset exposure, business impact or control effectiveness and does not replace CVSS or a human risk decision.

Optional official sources

National CERT insights
?CERT means Computer Emergency Response Team; CSIRT is the closely related term Computer Security Incident Response Team.

Choose official national sources for this report. Each advisory shows its original language. Your selection is remembered on this device and included in shared links.

Official European source

ENISA European Vulnerability Database

Official EUVD identifiers, advisory evidence and known-exploited context. Missing fields are not treated as evidence of low risk.

1 current
ENISA EUVD identifier

EUVD-2018-2671

No EUVD known-exploited evidence

ENISA has published the identifier mapping but no EUVD description has been stored yet.

EUVD state
Present in the current official mapping
Known exploitation
Not present in the current ENISA EUVD known-exploited dataset. This is not proof of no exploitation.
ENISA score
Not supplied in the stored EUVD record
Advisory evidence
No linked advisory details stored yet
Recommended actionScheduled

Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.

Fix not verified
01

What, why and how

IntelliVue Patient Monitors MP Series (including MP2/X2/MP30/MP50/MP70/NP90/MX700/800) Rev B-M, IntelliVue Patient Monitors MX (MX400-550) Rev J-M and (X3/MX100 for Rev M only), and Avalon Fetal/Maternal Monitors FM20/FM30/FM40/FM50 with software Revisions F.0, G.0 and J.3 have a vulnerability that allows an unauthenticated attacker to read memory from an attacker-chosen device address within the same subnet.

What

IntelliVue Patient Monitors MP Series (including MP2/X2/MP30/MP50/MP70/NP90/MX700/800) Rev B-M, IntelliVue Patient Monitors MX (MX400-550) Rev J-M and (X3/MX100 for Rev M only), and Avalon Fetal/Maternal Monitors FM20/FM30/FM40/FM50 with software Revisions F.0, G.0 and J.3 have a vulnerability that allows an unauthenticated attacker to read memory from an attacker-chosen device address within the same subnet.

Why

The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.

How

An attacker operating through the affected interface may attempt exploitation without authentication or user interaction. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.

What

IntelliVue Patient Monitors MP Series (including MP2/X2/MP30/MP50/MP70/NP90/MX700/800) Rev B-M, IntelliVue Patient Monitors MX (MX400-550) Rev J-M and (X3/MX100 for Rev M only), and Avalon Fetal/Maternal Monitors FM20/FM30/FM40/FM50 with software Revisions F.0, G.0 and J.3 have a vulnerability that allows an unauthenticated attacker to read memory from an attacker-chosen device address within the same subnet.

Why

The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.

How

An attacker operating through the affected interface may attempt exploitation without authentication or user interaction. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.

02

Exploit reality and attack path

CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.

Observed exploitation
?Confirmed exploitation and public exploit material are separate signals. Attacks can occur without public proof-of-concept or exploit code.
No confirmed evidence

No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.

Public PoC / exploit material
?Confirmed exploitation and public exploit material are separate signals. Attacks can occur without public proof-of-concept or exploit code.
None recorded

No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.

Likely attack path
the affected interface → Exposure of Sensitive Information to an Unauthorized Actor → cause the confidentiality, integrity or availability impact described by the vendor
Attack surface
Unspecified
Privileges required
None: unauthenticated exploitation is possible
User interaction
None
Attack complexity
High: exploitation depends on specific conditions
Security boundary
Unchanged: impact remains within the vulnerable component's security authority
Weakness
?CWE means Common Weakness Enumeration: a standard category for the underlying weakness.
CWE-200 ↗

CWE-200: Exposure of Sensitive Information to an Unauthorized Actor. The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.

CVSS vector
?CVSS means Common Vulnerability Scoring System. The vector records the metric values used to calculate technical severity.
CVSS:3.0/AV:A/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N

Common Vulnerability Scoring System 3.0: the compact vector below is decoded into plain language.

AVAdjacentAttack vector: The attacker must be on an adjacent or logically close network.ACHighAttack complexity: Successful exploitation depends on specific conditions outside the attacker's direct control.PRNonePrivileges required: The attacker does not need an account or existing privileges.UINoneUser interaction: No action by another user is required.SUnchangedScope: The security impact remains within the vulnerable component's authority.CHighConfidentiality impact: A successful attack can cause a major loss.INoneIntegrity impact: No direct loss is represented by this metric.ANoneAvailability impact: No direct loss is represented by this metric.
Post-exploitation / living off the land
No specific living-off-the-land technique is confirmed in the structured sources. Monitor normal administration tools for activity inconsistent with the affected service's baseline.
UnauthenticatedCWE-200
A

Official authority intelligence

Only matched European and national findings are included. Language selectors and unavailable sources are omitted.

JVN iPedia · Japanese · JVNDB-2018-006287複数の Philips 製品における情報漏えいに関する脆弱性

複数の Philips 製品には、情報漏えいに関する脆弱性が存在します。

Official advisory ↗
03

Patch and workaround

Operational remediation based on structured source evidence.

Status
?Patch availability is based on structured fixed-version fields and authoritative update references. If no fix is verified, check the vendor advisory before making a change.
Fix not verified
Affected
IntelliVue Patient Monitors, Avalon Fetal/Maternal Monitors: The following IntelliVue Patient Monitors versions are affected: IntelliVue Patient Monitors MP Series (includingMP2/X2/MP30/MP50/MP70/NP90/MX700/800) Rev B-M, and IntelliVue Patient Monitors MX (MX400-550) Rev J-M and (X3/MX100 for Rev M only). The following Avalon Fetal/Maternal Monitors versions are affected: Avalon Fetal/Maternal Monitors FM20/FM30/FM40/FM50 with software Revisions F.0, G.0 and J.3
Fixed
No fixed version is explicitly recorded in the structured CVE data.
Action
No verified patch reference is present in the current structured sources. Check the vendor advisory before making a change.
Workaround
No verified workaround is recorded. Limit untrusted access and use least privilege until authoritative guidance is available.
04

Evidence and provenance

Published 5 Jun 2018 · Last source change 16 Sept 2024, 16:33 UTC · CWE-200 · Exposure of Sensitive Information to an Unauthorized Actor

CVE recordCVE.org · 5.1
CVSS sourceNIST NVD
EPSS source
?The date BlackTree first stored a score for this CVE from the daily FIRST EPSS feed.
FIRST · tracked since 2026-09-01
European sourceENISA EUVD · EUVD-2018-2671
Product sourceCNA
Remediation sourceCVE/CNA references
CWE sourceCNA
NVD statusNVD modified after enrichment

Core structured fields are present and their contributing authorities are shown above.

Material change intelligence

What changed after publication

View recent updates ↗
  1. ENISA EUVD mappingEUVD-2018-2671 was added to the official ENISA EUVD mapping for this CVE.
    Before
    not recorded
    After
    {"euvdId":"EUVD-2018-2671"}
    ENISA EUVD ↗
  2. SeveritySeverity changed from Unknown to Medium.
    Before
    Unknown
    After
    Medium
    NIST NVD ↗
  3. CVSS scoreCVSS score changed from not recorded to 5.3 (CVSS 3.0 · NIST NVD · CVSS:3.0/AV:A/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N).
    Before
    not recorded
    After
    5.3 (CVSS 3.0 · NIST NVD · CVSS:3.0/AV:A/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N)
    NIST NVD ↗
  4. Catalogue recordCVE added to the BlackTree catalogue.
    CNA ↗
Material fields only · duplicate refreshes suppressed · history retained for the configured operational retention period
CVE published
ENISA EUVD · EUVD-2018-2671↗CVE authority or vendor reference↗Official CVE record (CNA and ADP data)↗NVD record↗
Technical terms and abbreviations used in this report
CVE
Common Vulnerabilities and Exposures: the public identifier for one disclosed vulnerability.
CVSS
Common Vulnerability Scoring System: a technical severity framework; it is not patching priority by itself.
EPSS
Exploit Prediction Scoring System: FIRST's estimate of the probability that exploitation activity will be observed in the next 30 days; it is a forecast, not confirmation.
CWE
Common Weakness Enumeration: the standard category describing the underlying software or hardware weakness.
CNA
CVE Numbering Authority: an organisation authorised to assign and publish CVE records.
CISA ADP
Cybersecurity and Infrastructure Security Agency Authorized Data Publisher: structured enrichment added to a CVE record.
NVD
National Vulnerability Database: NIST's enrichment service for CVE records.
CERT / CSIRT
A computer security incident response team that publishes warnings or coordinates incident response.
PoC
Proof of concept: public material that demonstrates or helps reproduce exploitation.
CSAF
Common Security Advisory Framework: a machine-readable format for security advisories.
LoTL
Living off the land: abuse of legitimate tools or system functions during an attack.
Free version - for non-commercial use only.CVE-2018-10599 · cve.blacktree.nl